If you have any question, please feel free to email us. We will touch with you as soon as possible.
GAVRETO, also known as pralsetinib, is used to treat certain cancers caused by abnormal RET genes. For R&D purposes only.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
Generic name | Pralsetinib Capsules |
Trade name | GAVRETO/普吉华 |
Specification | 100mg |
Main ingredients | Pralsetinib |
Dosage Form | Capsule |
MA Holder | Genentech, Inc. (A Member of the Roche Group) |
Category | Reference Listed Drugs (RLDs) |
Indications:
GAVRETO is used to treat certain cancers caused by abnormal rearranged during transfection (RET) genes in:
1. adults with non-small cell lung cancer (NSCLC) that has spread;
2. adults and children 12 years of age and older with advanced medullary thyroid cancer (MTC) or MTC that has spread who require a medicine by mouth or injection (systemic therapy);
3. adults and children 12 years of age and older with advanced thyroid cancer or thyroid cancer that has spread who require a medicine by mouth or injection (systemic therapy) and who have received radioactive iodine and it did not work or is no longer working.
For more details, pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: pralsetinib capsules reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Agomelatine Tablets, Argatroban Injection, Olanzapine Tablets, AdapaleneGel, Phenytoin Sodium Tablets, Alfacalcidol Soft Capsules
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China